Cardio Exam 2

The TIMI (Thrombolysis In Myocardial Infarction) score is a risk assessment tool used to evaluate the likelihood of adverse cardiac events in patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI). A higher score indicates a greater risk of mortality and complications.

Clopidogrel is an antiplatelet medication that inhibits platelet aggregation. It is commonly used in acute coronary syndrome to prevent thrombus formation and is often administered in conjunction with aspirin.

Inverted T waves can indicate myocardial ischemia or infarction. They are often seen in patients with acute coronary syndromes.

Amiodarone is an antiarrhythmic medication that works by prolonging the action potential and refractory period in myocardial tissue, thereby stabilizing heart rhythm.

In a hemodynamically stable patient with atrial flutter, rate control can be achieved with medications such as diltiazem or beta-blockers, while rhythm control can be attempted with antiarrhythmics like amiodarone.

Troponin levels are biomarkers used to diagnose myocardial injury. Elevated troponin levels indicate damage to the heart muscle, often seen in conditions like myocardial infarction.

Unfractionated heparin (UFH) is often preferred for VTE prophylaxis in patients with renal impairment due to its predictable pharmacokinetics and ease of monitoring.

Common side effects of amlodipine include peripheral edema, flushing, palpitations, and dizziness. It is a calcium channel blocker used to treat hypertension and angina.

Alteplase is a thrombolytic agent used to dissolve blood clots in patients with ST-elevation myocardial infarction (STEMI) to restore blood flow to the heart.

Hydrochlorothiazide can increase the risk of QT prolongation when used with dofetilide, which can lead to serious arrhythmias.